Professor Michael Frenneaux qualified from Westminster Medical School in 1980 and was awarded the Gold Medal for the highest overall marks in the MB BS final examinations from the (then) 12 medical schools in the University of London.
After Senior House Officer posts at Hammersmith and Brompton Hospitals and the National Hospital for Neurology and Neurosurgery, Queen Square, he trained in clinical cardiology and undertook research in Edinburgh, Hammersmith and St George’s Hospitals in London and Christchurch, New Zealand.
He was appointed Clinical Senior Lecturer (University of Queensland) and Clinical Director of Cardiology at Royal Brisbane Hospital, Australia, in 1991, where he was subsequently promoted to Professor of Medicine, taking on the additional role of Deputy Director of Medicine for the hospital. Subsequently, he held the British Heart Foundation (BHF) Chairs of Cardiology in Cardiff and Birmingham, prior to being appointed to the Regius Chair of Medicine in Aberdeen in 2009 (the oldest Chair of Medicine in the English-speaking world and with appointment approved by the Queen), before taking up the role of Dean of Norwich Medical School. From May 2018 to July 2023, he was Chief of Scientific, Academic and Faculty Affairs at Hamad Medical Corporation and is now Advisor to the Minister of Public Health, with particular responsibility for advancing Qatar’s National Academic Health System.
He is Honorary Professor of Medicine at the University of Aberdeen, Visiting Professor of Medicine at Imperial College London, Adjunct Professor at Hamad Bin Khalifa University, Qatar and Honorary Consultant Cardiologist at the Royal Brompton Hospital, London.
His clinical activity is in heart failure and in inherited cardiac conditions. He is a clinician scientist, who has made significant contributions to the understanding of the pathophysiology of heart muscle diseases and heart failure, including cardiac energetic impairment, and the role of metabolic therapies, and also to the understanding of arterial pathophysiology. He is a Fellow of the Academy of Medical Sciences.

Prof. Andrew J Stewart Coats is a leading academic cardiologist specializing in heart failure. He is the Past President of the Heart Failure Association of the ESC (HFA), and was awarded the Linacre Gold Medal of Royal College of Physicians and the inaugural Michael L Pollock Award of the American Heart Association for his research in the field. Andrew has previously held the roles of Dean of the Royal Australasian College of Physicians, Joint Academic Vice-President of the University of Warwick, UK, and Monash University, Australia and CEO of the Norwich Research and Innovation Park. Prior to this he was Dean of Medicine and Deputy Vice-Chancellor of the University of Sydney, and head of Cardiology at Imperial College London. Andrew was born and schooled in Melbourne and studied medicine at Oxford and Cambridge. He has more than 140,000 citations, and an H-index of 151. He served as Editor-in-Chief of the International Journal of Cardiology from1999 to 2016. Andrew has been Chairman or Committee member of multiple major clinical trials. Andrew is a trained and experienced company director with an MBA from London Business school. He has been awarded more than 20 patents and has founded three successful biotech companies PsiOxus, Actimed and MateraCor. He was made Officer in the Order of Australia (AO) in 2017.